DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial

BACKGROUND: The efficacy of current influenza vaccines is limited in vulnerable populations. DNA vaccines can be produced rapidly, and may offer a potential strategy to improve vaccine immunogenicity, indicated by studies with H5 influenza DNA vaccine prime followed by inactivated vaccine boost. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledgerwood, Julie E., Bellamy, Abbie R., Belshe, Robert, Bernstein, David I., Edupuganti, Srilatha, Patel, Shital M., Renehan, Phyllis, Zajdowicz, Thad, Schwartz, Richard, Koup, Richard, Bailer, Robert T., Yamshchikov, Galina V., Enama, Mary E., Sarwar, Uzma, Larkin, Brenda, Graham, Barney S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423975/
https://www.ncbi.nlm.nih.gov/pubmed/25950433
http://dx.doi.org/10.1371/journal.pone.0125914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423975/
https://www.ncbi.nlm.nih.gov/pubmed/25950433
http://dx.doi.org/10.1371/journal.pone.0125914

Ejemplares similares